Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055180

EVP and Chief Medical Officer sold 262 shares at $88.00 ($23,056)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · EVP and Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-14 Sale : show line 1 in the form −262 $88.00 $23,056 35,789 D
Open-market sales · 262 sh · avg $88.00 · $23,056
Loading xslF345X03/doc4.xml…